DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on March 12, 2007; DOI: 10.1124/dmd.106.014340


0090-9556/07/3506-995-1000$20.00
DMD 35:995-1000, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.106.014340v1
35/6/995    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fisher, C. D.
Right arrow Articles by Cherrington, N. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fisher, C. D.
Right arrow Articles by Cherrington, N. J.

Induction of Drug-Metabolizing Enzymes by Garlic and Allyl Sulfide Compounds via Activation of Constitutive Androstane Receptor and Nuclear Factor E2-Related Factor 2

Craig D. Fisher, Lisa M. Augustine, Jonathan M. Maher, David M. Nelson, Angela L. Slitt, Curtis D. Klaassen, Lois D. Lehman-McKeeman, and Nathan J. Cherrington

Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona (C.D.F., L.M.A., N.J.C.); Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas (J.M.M., C.D.K.); Department of Discovery Toxicology, Bristol-Myers Squibb, Princeton, New Jersey (D.M.N., L.D.L.-M.); and Department of Biomedical Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, Rhode Island (A.L.S.)

Garlic oil (GO) contains several linear sulfur compounds, including diallyl sulfide (DAS), diallyl disulfide (DADS), and diallyl trisulfide (DATS), that induce drug-metabolizing enzymes such as CYP2B and NAD(P)H quinone oxidoreductase 1 (NQO1). CYP2B and NQO1 are primarily regulated by constitutive androstane receptor (CAR) and nuclear factor E2-related factor 2 (Nrf2) transcription factors, respectively. The purpose of this study was to determine whether GO and its specific constituents induce these two enzymes via CAR and Nrf2 activation. Female Wistar-Kyoto (WKY) rats express little CAR protein and exhibit less induction of CYP2B1/2 than males. GO, DAS, and DADS, but not DATS, induced CYP2B1/2 mRNA levels to a greater extent in WKY males than in females, suggesting CAR activation. Conversely, DAS induced NQO1 levels equally in WKY males and females, indicating CAR-independent induction in rats. DAS, but not GO, DADS, or DATS, induced CYP2B10 mRNA levels 530-fold in wild-type (WT) mice, whereas this induction was attenuated in CAR-/- mice. DAS induced NQO1 in WT and CAR-/- mice equally, suggesting CAR-independent induction in mice. DAS induced NQO1 5-fold in WT mice, whereas induction was completely absent in Nrf2-/- mice, indicating DAS also activates Nrf2. DAS induction of CYP2B10 mRNA was independent of Nrf2 presence or absence. In in vivo transcription assays, DAS activated the human CYP2B6 promoter, and the antioxidant response element of the human NQO1 promoter, respectively. These studies indicate that GO constituents, particularly DAS, activate CAR and Nrf2 to induce drug-metabolizing enzymes.


Address correspondence to: Nathan J. Cherrington, Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, 1703 East Mabel, Tucson, AZ 85721. E-mail: cherrington{at}pharmacy.arizona.edu




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
J. O. Ban, H. S. Lee, H.-S. Jeong, S. Song, B. Y. Hwang, D. C. Moon, D. Y. Yoon, S. B. Han, and J. T. Hong
Thiacremonone Augments Chemotherapeutic Agent-Induced Growth Inhibition in Human Colon Cancer Cells through Inactivation of Nuclear Factor-{kappa}B
Mol. Cancer Res., June 1, 2009; 7(6): 870 - 879.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
W. S. Baldwin and J. A. Roling
A Concentration Addition Model for the Activation of the Constitutive Androstane Receptor by Xenobiotic Mixtures
Toxicol. Sci., January 1, 2009; 107(1): 93 - 105.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. D. Merrell, J. P. Jackson, L. M. Augustine, C. D. Fisher, A. L. Slitt, J. M. Maher, W. Huang, D. D. Moore, Y. Zhang, C. D. Klaassen, et al.
The Nrf2 Activator Oltipraz Also Activates the Constitutive Androstane Receptor
Drug Metab. Dispos., August 1, 2008; 36(8): 1716 - 1721.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.